This week, the Infection Prevention community was greeted with news of notable shifts in American health leadership. The Senate confirmed Marty Makary and Jay Bhattacharya to fill the substantial roles of FDA commissioner and director of National Institutes of Health, respectively. While both faced questions regarding their stances on vaccines and the Department of Government Service’s workforce shakeups, they eventually passed Senate scrutiny, paving the way for their new leadership roles.
Furthermore, Susan Monarez, PhD, was named as the potential leader for the Health and Human Services (HHS) agency, adding another significant name to the new health leadership roster. Monarez’s nomination comes in light of the administration’s first choice, Dave Weldon, MD, whose nomination fell through due to controversial remarks on vaccines and autism. Amid the current climate of depleted CDC funding for programs focused on long COVID symptoms, the hope is for renewed, proactive leadership advocating for public health’s critical role. The disturbing spread of health disinformation also underlines the need for strong leadership in the public health sphere.
On the disease outbreak front, the measles outbreak surged further across the United States this week. An alarming increase of 18 cases in Texas has brought the total number up to 327 cases for the year 2025. Concurrently, New Mexico is grappling with 43 confirmed cases of the disease. Adding to concerns was last week’s exposure event at a hospital labor and delivery unit. Nationwide, cases have risen to 378 with a disconcerting large majority of cases concentrated amongst those aged between 5 to 19 years and 64 hospitalizations. Emphasizing the importance of vaccinations and booster shots is crucial in tackling the surge in measles cases.
Further echoing the importance of infection prevention, the Agency for Healthcare Research and Quality (AHRQ) now stands at the frontline, warding off preventable patient harm as infection preventionists are facing layoffs amid strained health care systems. The threat of severe cuts to the AHRQ underscores the urgent need to preserve advances made in patient safety to date.
Finally, the emergence of learning resources and events aimed at enhancing infection prevention education and networking is promising – from sterile processing conferences featuring expert speakers and innovative tools, to updated guidance on material compatibility with sterilization modalities provided by AAMI TIR17:2024. Resources like the Bug of the Month, offering valuable insight into prevalent and emerging pathogens, continue to be instrumental in educating healthcare professionals in the current health landscape.